BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29049112)

  • 1. America's Opioid Epidemic: Supply and Demand Considerations.
    Clark DJ; Schumacher MA
    Anesth Analg; 2017 Nov; 125(5):1667-1674. PubMed ID: 29049112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.
    Hah JM; Bateman BT; Ratliff J; Curtin C; Sun E
    Anesth Analg; 2017 Nov; 125(5):1733-1740. PubMed ID: 29049117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Health Policy Strategies to Address the Opioid Epidemic.
    Holton D; White E; McCarty D
    Clin Pharmacol Ther; 2018 Jun; 103(6):959-962. PubMed ID: 29384192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015-2017 National Survey on Drug Use and Health.
    Schuler MS; Dick AW; Stein BD
    J Gen Intern Med; 2020 Mar; 35(3):792-799. PubMed ID: 31792871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State Emergency Department Opioid Guidelines: Current Status.
    Broida RI; Gronowski T; Kalnow AF; Little AG; Lloyd CM
    West J Emerg Med; 2017 Apr; 18(3):340-344. PubMed ID: 28435482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Fischer B; Pang M; Jones W
    Subst Abuse Treat Prev Policy; 2020 Feb; 15(1):14. PubMed ID: 32066470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.
    Beauchamp GA; Winstanley EL; Ryan SA; Lyons MS
    Am J Public Health; 2014 Nov; 104(11):2023-9. PubMed ID: 25211712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Opioid Misuse in Older Adult Surgical Patients: Epidemiology, Prevention, and Clinical Implications.
    Dahlem CH; Schepis TS; McCabe SE; Rank AL; Kcomt L; McCabe VV; Voepel-Lewis T
    J Addict Nurs; 2022 Oct-Dec 01; 33(4):218-232. PubMed ID: 37140410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.
    Brady KT; McCauley JL; Back SE
    Am J Psychiatry; 2016 Jan; 173(1):18-26. PubMed ID: 26337039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum Opioid Prescribing and Persistent Use in Western Countries.
    Poeran J; Park CH
    Anesth Analg; 2024 May; 138(5):967-969. PubMed ID: 38621284
    [No Abstract]   [Full Text] [Related]  

  • 11. Oregon's strategy to confront prescription opioid misuse: a case study.
    McCarty D; Bovett R; Burns T; Cushing J; Glynn ME; Kruse SJ; Millet LM; Shames J
    J Subst Abuse Treat; 2015 Jan; 48(1):91-5. PubMed ID: 25168199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.
    Cerdá M; Krawczyk N; Hamilton L; Rudolph KE; Friedman SR; Keyes KM
    Annu Rev Public Health; 2021 Apr; 42():95-114. PubMed ID: 33256535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Federal Response to the Opioid Crisis.
    Johnson K; Jones C; Compton W; Baldwin G; Fan J; Mermin J; Bennett J
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):293-301. PubMed ID: 29968173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Overdose Deaths and Florida's Crackdown on Pill Mills.
    Kennedy-Hendricks A; Richey M; McGinty EE; Stuart EA; Barry CL; Webster DW
    Am J Public Health; 2016 Feb; 106(2):291-7. PubMed ID: 26691121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.
    Dasgupta N; Beletsky L; Ciccarone D
    Am J Public Health; 2018 Feb; 108(2):182-186. PubMed ID: 29267060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piloting an Opioid Risk Screening Tool in Clinical Practice.
    Aneke G; Forehand JW; Simpler B; Dunagan A
    J Dr Nurs Pract; 2024 Mar; 17(1):11-20. PubMed ID: 38538114
    [No Abstract]   [Full Text] [Related]  

  • 17. The Opioid Industry Documents Archive: Advancing Public Health Through Industry Document Disclosure.
    Caleb Alexander G; Tasker K
    J Law Med Ethics; 2024; 52(1):133-135. PubMed ID: 38818587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America.
    Fischer B; O'Keefe-Markman C; Lee AM; Daldegan-Bueno D
    Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):17. PubMed ID: 33588896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A call to develop opioid risk assessment programs for implementation in the pharmacy setting.
    Hodges A; Skarphol A; Strand MA
    J Am Pharm Assoc (2003); 2024; 64(2):350-354. PubMed ID: 37866627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D.
    Powell D; Pacula RL; Taylor E
    J Health Econ; 2020 May; 71():102286. PubMed ID: 32193022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.